Nektar Therapeutics
Clinical trials sponsored by Nektar Therapeutics, explained in plain language.
A biopharmaceutical company developing polymer-based drug conjugates.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New eczema drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called rezpegaldesleukin for adults with moderate-to-severe eczema (atopic dermatitis). About 396 participants will receive either the drug or a placebo for 16 weeks, and those who improve may continue treatment for up to a year. The goal is …
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug aims to regrow hair in severe baldness disorder
Disease control OngoingThis study tests an experimental drug called rezpegaldesleukin in 94 adults with severe to very severe alopecia areata, a condition causing significant hair loss. Participants receive either the drug or a placebo for 36 weeks, with an optional extension. The main goal is to measu…
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC